Abstract 4361: Retinoblastoma (RB) genomic progression analysis using Tissue Microarrays (TMA) comprising 121 RB patient tumors
Crystal N. D'Silva(Queen's University), Jeremy A. Squire(Universidade de São Paulo), Renato José Mendonça Natalino(Instituto do Câncer do Estado de São Paulo), Karina Braga Ribeiro(AC Camargo Hospital), William Halliday(University of Toronto), Maisa Yoshimoto(University of Alberta), Fernando Augusto Soares(University of Connecticut), Célia Beatriz Gianotti Antoneli(AC Camargo Hospital), Brenda L. Gallie(University of Toronto)
Cited by 0
Related Papers
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
|The Lancet Oncology|2013|419
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
|Journal of Clinical Oncology|2011|256
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
|The Journal of Pathology|2009|210